Leflunomide therapy-associated tuberculosis infection

被引：0
作者：
Wang, Feng [1 ]
Bai, Mei [1 ]
Wang, Niansong [1 ]
机构：
[1] Shanghai Jiao Tong Univ, Shanghai Peoples Hosp 6, Dept Nephrol & Rheumatol, Shanghai, Peoples R China
来源：
AFRICAN JOURNAL OF MICROBIOLOGY RESEARCH | 2012年 / 6卷 / 09期
关键词：
tuberculosis; leflunomide; side effect; RHEUMATOID-ARTHRITIS; TRIAL;
D O I：
10.5897/AJMR11.969
中图分类号：
Q93 [微生物学];
学科分类号：
071005 ; 100705 ;
摘要：
Leflunomide is a new type of immunosuppressive agent for treatment of rheumatoid arthritis and good efficacy has been obtained in clinical practice. These past years, leflunomide has been used for treatments of not only rheumatoid arthritis but also glomerulonephritis and ankylosing spondylitis. A case is presented that a male patient diagnosed ankylosing spondylitis and treated with leflunomide experienced tuberculosis of lymph nodes. The side effects of leflunomide were suspected and a literature review is followed. It was concluded that tuberculosis infection in this case might be a result of leflunomide therapy partly. Clinical concern should be put to inpatients treated with leflunomide.
引用
收藏
页码：1884 / 1886
页数：3
相关论文
共 12 条
[1]   Frequency and tolerance of antituberculosis treatment according to national guidelines for prevention of risk of tuberculosis due to tumor necrosis factor blocker treatment [J].
Bray, Marie-Gaelle ;
Poulain, Cecile ;
Dougados, Maxime ;
Gossec, Laure .
JOINT BONE SPINE, 2010, 77 (02) :135-141
[2]   When a DMARD fails, should patients switch to sulfasalazine or add sulfasalazine to continuing leflunomide? [J].
Dougados, M ;
Emery, P ;
Lemmel, EM ;
Zerbini, CAF ;
Brin, S ;
van Riel, P .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (01) :44-51
[3]   Severe infections following leflunomide therapy for rheumatoid arthritis [J].
Grover, R. ;
Dhir, V. ;
Aneja, R. ;
Arya, V. ;
Galle, A. ;
Marwaha, V. ;
Kumar, A. .
RHEUMATOLOGY, 2006, 45 (07) :918-920
[4]   Six months open label trial of leflunomide in active ankylosing spondylitis [J].
Haibel, H ;
Rudwaleit, M ;
Braun, J ;
Sieper, J .
ANNALS OF THE RHEUMATIC DISEASES, 2005, 64 (01) :124-126
[5]   Leflunomide-associated tuberculosis? [J].
Hocevar, A ;
Rozman, B ;
Praprotnik, S ;
Lestan, B ;
Erzen, D ;
Petric, V ;
Tomsic, M .
RHEUMATOLOGY, 2006, 45 (02) :228-229
[6]   Long-term efficacy of leflunomide on disease activity and inhibition of joint damage: retrospective comparison with methotrexate for Japanese rheumatoid arthritis patients [J].
Katayama, Kou ;
Matsuno, Takeo .
MODERN RHEUMATOLOGY, 2009, 19 (05) :513-521
[7]   Randomised controlled trial of leflunomide in the treatment of immunoglobulin A nephropathy [J].
Lou, TQ ;
Wang, C ;
Chen, ZJ ;
Shi, CG ;
Tang, H ;
Liu, X ;
Yin, PD ;
Yu, XQ .
NEPHROLOGY, 2006, 11 (02) :113-116
[8]  
Pinto Patricia, 2006, Acta Reumatol Port, V31, P215
[9]   Leflunomide in Combination Therapy for Rheumatoid Arthritis [J].
Savage, Ruth L. .
DRUG SAFETY, 2010, 33 (06) :523-526
[10]   Leflunomide use and the risk of interstitial lung disease in rheumatoid arthritis [J].
Suissa, Samy ;
Hudson, Marie ;
Ernst, Pierre .
ARTHRITIS AND RHEUMATISM, 2006, 54 (05) :1435-1439
12